In colorectal cancer, EP4 occupation leads to ERK activation supporting anchorage-independent growth and resistance to apoptosis that is reversed by small molecule EP4 antagonists ONO-AE3-208 and AH23848 (Hawcroft et al., 2007). The gene discussed is PTGER4; the disease is colorectal cancer.